Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NBP606 vs Prevnar13 in Healthy Infants
NCT02201030Phase 3Completed
- Sponsor
- SK Chemicals
- Start
- Sep 2014
- Primary completion
- Oct 2016
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of NBP606 in pneumococcal infection, sponsored by SK Chemicals. Started Sep 2014; status: completed.
02
Drugs
NBP606
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT02201030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02201030.